Collectively, these data identify LRP2 and APOB as modulators of cell cycle and apoptosis in hiPSC-CMs, however, further validation is necessary to link them to contributing to the developmental cardiac impairment in HLHS patients. The gene discussed is APOB; the disease is hypoplastic left heart syndrome.